VIDEO: Stool-based CRC screening promises cost effectiveness

VIDEO: Stool-based CRC screening promises cost effectiveness

In a video exclusive, Paul Limburg, MD, Mayo Clinic, told Healio adherence rates for stool-based colorectal cancer screening and colonoscopy informed comparative effectiveness and the need for improved screening and follow-up adherence.“For our study we took guideline recommended stool-based screening strategies, the multi-target stool DNA test (mt-sDNA), the fecal immunochemical test and fecal occult blood…

VIDEO: Racial disparities present in adjuvant therapy for pancreatic cancer

VIDEO: Racial disparities present in adjuvant therapy for pancreatic cancer

In this video exclusive, Roi Anteby, MD, postdoctoral research fellow, department of surgery, Massachusetts General Hospital, discussed the affect of race, socioeconomic status and education on completion of adjuvant therapy for pancreatic cancer.“Our next research focuses on the underlying reasons for disparities of care in the United States,” he said. “We assume and other data…

VIDEO: Cirrhosis awareness key to liver health improvement in NASH

VIDEO: Cirrhosis awareness key to liver health improvement in NASH

In an exclusive video with Healio Gastroenterology, Eric Lawitz, MD, from the Texas Liver Institute, The University of Texas Health, San Antonio, spoke about the NAVIGATE trial in nonalcoholic steatohepatitis-related cirrhosis.This is a phase 2b/3 trial evaluating the use of belapectin in patients with NASH-cirrhosis and portal hypertension who have not yet developed esophageal varices.“This…

COVID-19 screening disruptions could lead to more colorectal cancers, deaths

COVID-19 screening disruptions could lead to more colorectal cancers, deaths

The COVID-19 pandemic disrupted colorectal cancer screening programs around the world.To explore the impact of disruptions to cancer screening of all types, the COVID-19 and Cancer Global Modelling Consortium was established to inform responses to screening disruptions and guide policy makers and prevention practices during and after the pandemic.Using well-established and validated decision models, we…

| |

2021 Legislative Session Wrap-Up

Christopher L. Nuland, Esq.Lobbyist and Counsel In what was undoubtedly the most challenging Session ever for both legislators and lobbyists, whose interactions were minimized by Covid protocols, we did emerge with several notable victories and some “near-misses” that we will engage in next year. One of our biggest victories was the passage of a Covid…